These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 2860675)

  • 1. N-acetylation pharmacogenetics.
    Weber WW; Hein DW
    Pharmacol Rev; 1985 Mar; 37(1):25-79. PubMed ID: 2860675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of drug preparations metabolized by N-acetyltransferase].
    Skakun NP
    Klin Med (Mosk); 1982 Jan; 60(1):24-7. PubMed ID: 6122757
    [No Abstract]   [Full Text] [Related]  

  • 3. Acetyl-CoA dependent O-acetylation of N-hydroxyarylamines in bacterial and mammalian cells--the significance for mutagenesis and carcinogenesis.
    Kato R; Kamataki T; Saito K; Shinohara A
    Prog Clin Biol Res; 1986; 209A():507-14. PubMed ID: 3529109
    [No Abstract]   [Full Text] [Related]  

  • 4. Inherited defects of hepatic drug metabolism.
    Küpfer A; Preisig R
    Semin Liver Dis; 1983 Nov; 3(4):341-54. PubMed ID: 6417793
    [No Abstract]   [Full Text] [Related]  

  • 5. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
    Andres HH; Weber WW
    Drug Metab Dispos; 1986; 14(4):382-5. PubMed ID: 2873982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease and acetylation polymorphism.
    Lunde PK; Frislid K; Hansteen V
    Clin Pharmacokinet; 1977; 2(3):182-97. PubMed ID: 328206
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylation pharmacogenetics: experimental models for human toxicity.
    Weber WW
    Fed Proc; 1984 May; 43(8):2332-7. PubMed ID: 6714442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity.
    Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R
    Cancer Res; 1986 Sep; 46(9):4362-7. PubMed ID: 3731093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical consequences of acetylation polymorphism].
    Jendryczko A; Gmiński J
    Pol Tyg Lek; 1984 Sep; 39(37):1249-52. PubMed ID: 6150471
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetic polymorphism of drug metabolism.
    Paxton JW
    N Z Med J; 1984 Aug; 97(762):567-9. PubMed ID: 6591031
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug acetylator phenotypes in newborn infants.
    Szórády I; Sánta A; Veress I
    Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):23-5. PubMed ID: 3580445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster.
    Hein DW; Omichinski JG; Brewer JA; Weber WW
    J Pharmacol Exp Ther; 1982 Jan; 220(1):8-15. PubMed ID: 7053425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster.
    Hein DW; Kirlin WG; Ferguson RJ; Weber WW
    J Pharmacol Exp Ther; 1985 Aug; 234(2):358-64. PubMed ID: 3874952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hydralazine and other drugs on the kinetics of procainamide acetylation by rat liver and kidney N-acetyltransferase.
    Schneck DW; Sprouse JS; Hayes AH; Shiroff RA
    J Pharmacol Exp Ther; 1978 Jan; 204(1):212-8. PubMed ID: 619131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic N-acetylation of phenelzine and monoacetylhydrazine by highly purified rabbit liver isoniazid N-acetyltransferase.
    Hein DW; Weber WW
    Drug Metab Dispos; 1982; 10(3):225-9. PubMed ID: 6125354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
    Palamanda JR; Hickman D; Ward A; Sim E; Romkes-Sparks M; Unadkat JD
    Drug Metab Dispos; 1995 Apr; 23(4):473-7. PubMed ID: 7600914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic differences in reactions to drugs and other xenobiotics outlook of a geneticist.
    Goedde HW
    Prog Clin Biol Res; 1986; 214():9-20. PubMed ID: 3460099
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
    Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
    Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacogenetics and its importance in the clinical].
    Lares-Asseff I; Trujillo-Jiménez F
    Gac Med Mex; 2001; 137(3):227-36. PubMed ID: 11432091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.